New targeted radiation therapy shows promise for advanced liver cancer
Disease control
Recruiting now
This study tests a drug called 177Lu-PSMA-617 in people with liver cancer that has spread and shows a specific marker (PSMA) on scans. The goal is to see if the drug is safe and can shrink tumors. About 10 adults who have already tried one standard treatment will receive this tar…
Phase: PHASE2 • Sponsor: Melissa Lumish • Aim: Disease control
Last updated May 12, 2026 13:40 UTC